Buscar

Estamos realizando la búsqueda. Por favor, espere...

 Detalle_Publicacion

Elevated risk of liver steatosis in first-episode psychosis patients: Results from a 3-year prospective study

Abstract: Background Cardiometabolic disorders are largely responsible for excess mortality in schizophrenia. Non-alcoholic fatty liver disease (NAFLD) is increasingly relevant in the development of metabolic risk factors that have been associated with antipsychotic treatment. We aimed to assess the incidence of NAFLD and metabolic disturbances during the first 3 years of antipsychotic treatment in patients with first episode of psychosis (FEP), and compare it with the incidence in a control group. Methods Data were obtained from patients with psychosis (n = 160) and healthy controls (n = 66) included in the Cantabria's clinical and research program on FEP (PAFIP) from 2012 to 2018. Fatty Liver Index (FLI) was used to estimate the amount of fat in the liver. FLI has been validated for the diagnosis of NAFLD against different standards such as liver ultrasound and biopsy. FLI and metabolic parameters were registered at baseline, 3 months and then yearly for 3 years. Results At the end of the follow-up (3-years), 21.9 % of patients with psychosis developed a FLI ? 60, suggestive of liver steatosis, compared to only a 3 % of subjects within the control group (X2 = 12.120; p < 0.001). In the FEP patients group, developing a FLI ? 60 was statistically associated with significant increments in metabolic parameters, and with Metabolic Syndrome (MetS) (X2 = 16.151; p < 0.001) and high blood pressure (X2 = 10.654; p = 0.001). Conclusions Having a first episode of non-affective psychosis was significantly associated with developing liver steatosis (FLI ? 60) in the first three years after initiating antipsychotic treatment. The results highlight the importance of early screening the emergence of NAFLD in schizophrenia patients.

Otras publicaciones de la misma revista o congreso con autores/as de la Universidad de Cantabria

 Fuente: Schizophrenia Research Volume 246, August 2022, Pages 30-38

Editorial: Elsevier

 Año de publicación: 2022

Nº de páginas: 9

Tipo de publicación: Artículo de Revista

 DOI: 10.1016/j.schres.2022.06.001

ISSN: 0920-9964,1573-2509

Url de la publicación: https://doi.org/10.1016/j.schres.2022.06.001

Autores/as

GALIANO RUS, SARA

ORTIZ GARCÍA DE LA FOZ, VÍCTOR

ARIAS-LOSTE, MARÍA TERESA

IRUZUBIETA, PAULA

GÓMEZ REVUELTA, MARCOS

JUNCAL-RUIZ, MARÍA

CRESPO FACORRO, BENEDICTO